Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crosstree Capital Securities, LLC is a broker-dealer and investment banking firm that provides M&A advisory and financial services exclusively to the health sciences industry. It is not a biotech, pharma, CRO, or CMO company, but rather a financial services provider serving those industries. The firm was formed on July 21, 2008, as a Florida limited liability company and is affiliated with Crosstree Capital Partners, Inc., a management consulting firm, through common ownership. It is regulated by FINRA and the SEC. The firm specializes in pharmaceutical outsourcing, diagnostic products and services, and life science tools, providing investment banking and corporate finance advisory services regarding mergers and acquisitions and growth capital financing. Since its parent company's founding in 2004, the organization has completed over 200 health sciences transactions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crosstree Capital Securities.